AllianceBernstein’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-58,600
| Closed | -$357K | – | 3394 |
|
|
2021
Q3 | $357K | Hold |
58,600
| – | – | ﹤0.01% | 2898 |
|
|
2021
Q2 | $482K | Buy |
58,600
+10,800
| +23% | +$91.8K | ﹤0.01% | 2830 |
|
|
2021
Q1 | $428K | Sell |
47,800
-4,900
| -9% | -$56.2K | ﹤0.01% | 2731 |
|
|
2020
Q4 | $608K | Hold |
52,700
| – | – | ﹤0.01% | 2500 |
|
|
2020
Q3 | $549K | Sell |
52,700
-1,400
| -3% | -$17.2K | ﹤0.01% | 2478 |
|
|
2020
Q2 | $711K | Sell |
54,100
-7,600
| -12% | -$78.8K | ﹤0.01% | 2392 |
|
|
2020
Q1 | $486K | Buy |
61,700
+9,700
| +19% | +$146K | ﹤0.01% | 2371 |
|
|
2019
Q4 | $1.08M | Hold |
52,000
| – | – | ﹤0.01% | 2253 |
|
|
2019
Q3 | $713K | Hold |
52,000
| – | – | ﹤0.01% | 2396 |
|
|
2019
Q2 | $640K | Buy |
52,000
+4,900
| +10% | +$56.5K | ﹤0.01% | 2504 |
|
|
2019
Q1 | $588K | Hold |
47,100
| – | – | ﹤0.01% | 2461 |
|
|
2018
Q4 | $533K | Hold |
47,100
| – | – | ﹤0.01% | 2453 |
|
|
2018
Q3 | $881K | Hold |
47,100
| – | – | ﹤0.01% | 2393 |
|
|
2018
Q2 | $1.22M | Buy |
47,100
+15,000
| +47% | +$389K | ﹤0.01% | 2221 |
|
|
2018
Q1 | $719K | Hold |
32,100
| – | – | ﹤0.01% | 2400 |
|
|
2017
Q4 | $804K | Hold |
32,100
| – | – | ﹤0.01% | 2385 |
|
|
2017
Q3 | $776K | Sell |
32,100
-12,500
| -28% | -$294K | ﹤0.01% | 2408 |
|
|
2017
Q2 | $902K | Buy |
44,600
+18,600
| +72% | +$387K | ﹤0.01% | 2343 |
|
|
2017
Q1 | $700K | Hold |
26,000
| – | – | ﹤0.01% | 2414 |
|
|
2016
Q4 | $495K | Hold |
26,000
| – | – | ﹤0.01% | 2568 |
|
|
2016
Q3 | $508K | Hold |
26,000
| – | – | ﹤0.01% | 2527 |
|
|
2016
Q2 | $389K | Buy |
+26,000
| New | +$327K | ﹤0.01% | 2601 |
|
|
2015
Q2 | – | Sell |
-3,500
| Closed | -$79K | – | 3350 |
|
|
2015
Q1 | $79K | Buy |
3,500
+3,000
| +600% | +$69.5K | ﹤0.01% | 3062 |
|
|
2014
Q4 | $10K | Sell |
500
-200
| -29% | -$3.63K | ﹤0.01% | 3314 |
|
|
2014
Q3 | $13K | Sell |
700
-300
| -30% | -$4.34K | ﹤0.01% | 3259 |
|
|
2014
Q2 | $13K | Buy |
+1,000
| New | +$13.6K | ﹤0.01% | 3288 |
|
AllianceBernstein's FLXN Position: Q4 2021 in Review
AllianceBernstein sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 58,600 shares — an estimated $357K sold.
AllianceBernstein first reported a position in FLXN in Q2 2014 and held it in 26 quarters. The position peaked at $1.22M in Q2 2018. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.
- AllianceBernstein reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
- AllianceBernstein sold 58,600 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $357K.
- AllianceBernstein first reported a position in Flexion Therapeutics, Inc. in Q2 2014 and held it in 26 quarters.
- AllianceBernstein's Flexion Therapeutics, Inc. position peaked at $1.22M in Q2 2018.
- 1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.
Based on AllianceBernstein's 13F filing for Q4 2021, filed 14 Feb 2022.